Scientific Program Themes

  1. Diagnosis, phenotypes, and variants of MS and related disorders
  2. Factors that determine MS susceptibility, disease course, and prognosis: The roles and interactions of genetics, epigenetics, the microbiome, environmental factors, pregnancy, age, comorbidities, and risk behaviors in determining MS susceptibility and disease course
  3. Pathogenesis of MS relapses and progression: the link between inflammation and neurodegeneration
  4. Mechanisms, detection, and significance of gray matter pathology in MS
  5. Methods to monitor MS disease activity and severity: Patient self-report and automated self-assessment, new clinician-reported outcomes, standard and advanced imaging, and biomarkers
  6. Current, emerging, and future disease therapies for relapsing-remitting and progressive MS and related disorders
  7. Treatment strategies: Early treatment, switching therapies, treating-to-target of no evidence of disease activity, personalized treatment, and post-marketing monitoring of safety and efficacy
  8. Regeneration and repair: which strategies look promising and how do we test them
  9. Aspects of trial design in relapsing and progressive MS
  10. Rehabilitative strategies to restore function: Improving cognition, motor function, and mobility
  11. Management of the symptoms and other sequelae of MS
  12. Society and MS: roles of the expert patient, social media, and health policy



For more information on the program, support opportunities, or any general questions, please contact the ACTRIMS Secretariat.

22 North Carroll Street, Suite 300
Madison, Wisconsin 53703 USA

+ 1 608 310 8960

Logistics Secretariat

For more information about housing, registration, press, media and Boston in general, please contact the Logistics Secretariat.

c/o Opus 3 inc.
417 Saint-Pierre Street, Suite 302
MontrĂ©al QC H2Y 2M4 Canada

+ 1 514 395 1808

opus logo